Patents by Inventor Gareth Lewis

Gareth Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210352375
    Abstract: Systems, methods, and computer readable media are described for modifying or updating a user interface. In some examples, systems, methods, and computer readable media include receiving, via an operator console on an operator system, one or more inputs for a template for a user interface, generating, based on the one or more inputs, the template for the user interface, and generating, based on the template, a plurality of designs for the user interface, wherein each design in the plurality of designs is associated with an interface profile.
    Type: Application
    Filed: September 10, 2019
    Publication date: November 11, 2021
    Applicant: OpenTV, Inc.
    Inventors: Alex Fishman, Gareth Lewis, Will Owen, Lee Thomas, Crx Chai, Laurent Demesmaeker, Ben Gidley, Jain Ruchira
  • Publication number: 20210266455
    Abstract: According to embodiments of the disclosure, an image capture control system is provided, the image capture control system comprising circuitry configured to: receive image data of an imaging environment from an image capture device; identify a selection of a first imaging zone of a plurality of pre-configured imaging zones within the imaging environment as an active imaging zone; control the image capture device based on the identification of the active imaging zone to capture image data of the active imaging zone; and perform processing on the captured image data of the active imaging zone based on the active imaging zone which has been selected.
    Type: Application
    Filed: January 5, 2021
    Publication date: August 26, 2021
    Applicants: Sony Europe B.V., Sony Corporation
    Inventors: Michael WILLIAMS, Gareth LEWIS, David TREPESS, Alan BIRTLES, Garry COX
  • Patent number: 9109873
    Abstract: An apparatus for inspecting a tip shroud includes a frame having top and bottom surfaces. A first stop is connected to the bottom surface to contact a first side surface of the tip shroud, and a second stop is in sliding engagement with the frame to contact a second side surface of the tip shroud. A method for inspecting a tip shroud includes placing an apparatus against the tip shroud, wherein the apparatus has a first stop connected to a frame and a second stop in sliding engagement with the frame. The method further includes engaging the first stop with a first side surface of the tip shroud and sliding the second stop with respect to the frame until the second stop contacts a second side surface of the tip shroud.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: August 18, 2015
    Assignee: General Electric Company
    Inventors: Gareth Lewis, John David Ward, Jr.
  • Patent number: 8849713
    Abstract: A transaction terminal system for a card-based purchase communicates with a host system to provide dynamic currency conversion. The transaction terminal system can select one of a number of different rate request messages according to various local factors in order to obtain a currency conversion rate for dynamic currency conversion.
    Type: Grant
    Filed: March 6, 2009
    Date of Patent: September 30, 2014
    Assignee: Global Blue Currency Choice Holdings B.V.
    Inventors: Sumithran Sivapathasundram, Puay Hiang Tan, Anthony Donohue, Gareth Lewis
  • Publication number: 20110004528
    Abstract: A payment terminal system for a card-based purchase can automatically determine a purchase that is potentially entitled to a tax refund from a billing currency for the payment card indicated in a purchase approval response message in response to payment authorisation request transmitted by the payment terminal system. Tax refund records are allocated. The tax refund records make reference to one or more reference currencies.
    Type: Application
    Filed: March 6, 2009
    Publication date: January 6, 2011
    Inventors: Anthony Donohue, Gareth Lewis
  • Publication number: 20080175910
    Abstract: The present invention relates to delayed release coated cores comprising an active substance in their core and a polymer coating comprising at least one or more ammonio methacrylate copolymer, characterized in that the core comprises at least a surfactant; to monolithic or multiparticulate pharmaceutical dosage forms comprising such delayed release coated cores and to their method of manufacture.
    Type: Application
    Filed: March 24, 2008
    Publication date: July 24, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Frederic ANDRE, Gareth LEWIS, Jerome MIGNONNEAU, Agnes RIBARDIERE
  • Publication number: 20080089936
    Abstract: The invention concerns a novel formulation for prolonged release of an active principle having a pH-dependent solubility. The inventive formulation comprises a matrix support based on hydrophilic polymer containing a specific dose of active principle, and further comprises one or more acidifying agents in the form of an acid salt of an organic acid.
    Type: Application
    Filed: December 3, 2007
    Publication date: April 17, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Gerard ALAUX, Frederic ANDRE, Gareth LEWIS, Veronique SERRE
  • Publication number: 20060159744
    Abstract: The present invention relates to timed dual release dosage forms of short acting hypnotics or salts thereof adapted to release the short acting hypnotic over a predetermined time period, according to a profile of dissolution characterized in that it comprises two release pulses, the first being immediate (lasting up to 30 minutes) and the second being delayed by a fixed time (this fixed time being between 50 and 200 minutes).
    Type: Application
    Filed: March 21, 2006
    Publication date: July 20, 2006
    Applicant: Sanofi-Aventis
    Inventors: Gerard Alaux, Frederic Andre, Jean Ducassou, Gareth Lewis
  • Publication number: 20060153925
    Abstract: The invention relates to a solid pharmaceutical composition for oral administration of amisulpride, which comprises at least one coated amisulpride particle and at least one pharmaceutically acceptable excipient suitable for an orodispersible administration of the composition.
    Type: Application
    Filed: January 6, 2006
    Publication date: July 13, 2006
    Applicant: Sanofi-Aventis
    Inventors: Frederic Andre, Henri Cruz, Michel Denni, Gareth Lewis, Jerome Mignonneau, Agnes Ribardiere
  • Publication number: 20060151536
    Abstract: A substance dispensing device is disclosed having a body that defines a chamber for receiving a substance capsule. The capsule is operable to dispense substance therefrom and has an outlet through which substance is dispensed. The body has two relatively movable parts that are moved relatively apart from a rest position to condition the device for use. A closure member associated with the movable part obstructs the outlet when the movable parts are in the rest position.
    Type: Application
    Filed: December 22, 2003
    Publication date: July 13, 2006
    Applicant: Acrux DDSpty ltd
    Inventors: Kon Wong, Mark Bayly, Gareth Lewis
  • Publication number: 20050202089
    Abstract: A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
    Type: Application
    Filed: January 3, 2005
    Publication date: September 15, 2005
    Applicant: SANOFI-SYNTHELABO
    Inventors: Maryvonne Chariot, Gareth Lewis, Jean Montel
  • Patent number: 6861072
    Abstract: The invention concerns a pharmaceutical composition with gastric residence and controlled release, characterized in that it comprises two or three layers and contains (a) an active principle associated with a excipient modifying its release; (b) a system generating carbon dioxide in a swelling polymer hydrophilic matrix; (a) and (b) capable of being included in a common layer or in separate layers.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: March 1, 2005
    Assignee: Sanofi-Synthelabo
    Inventors: Gérard Alaux, Frédéric Andre, Alain Cuine, Gareth Lewis
  • Publication number: 20040258750
    Abstract: Timed dual release dosage forms of short acting hypnotics or salts thereof adapted to release the short acting hypnotic over a predetermined time period according to a profile of dissolution comprising two release pulses, the first being immediate and the second being delayed by a fixed time after administration.
    Type: Application
    Filed: April 6, 2004
    Publication date: December 23, 2004
    Inventors: Gerard Alaux, Frederic Andre, Jean Ducassou, Gareth Lewis
  • Publication number: 20040050740
    Abstract: A tamper evident packaging system including a tag (10) attachable to a package comprising a substantially oxygen impermeable upper barrier layer (12a), a reactive intermediate layer (14) including a reactive material changeable between an un-reacted condition in the absence of oxygen and a reacted condition in the presence of oxygen to produce a visible colour change, and a lower layer (12b) which can be a substantially oxygen impermeable lower barrier layer or an integral part of the package.
    Type: Application
    Filed: July 21, 2003
    Publication date: March 18, 2004
    Inventor: Gareth Lewis
  • Patent number: 6514531
    Abstract: The present invention relates to controlled-release dosage forms of zolpidem or salts thereof adapted to release zolpidem over a predetermined time period, according to a biphasic profile of dissolution, where the first phase is an immediate release phase and the second phase is a prolonged release phase and particular embodiments thereof intended to avoid abuse.
    Type: Grant
    Filed: July 16, 2001
    Date of Patent: February 4, 2003
    Assignee: Sanofi-Synthelabo
    Inventors: Gérard Alaux, Gareth Lewis, Frédéric Andre
  • Patent number: 6165507
    Abstract: A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: December 26, 2000
    Assignee: Synthelabo
    Inventors: Maryvonne Chariot, Gareth Lewis, Jean Montel
  • Patent number: 5112621
    Abstract: A sustained-release pharmaceutical composition which comprises microparticles comprising an active principle, said microparticles being coated with a coating mixture comprising ethyl cellulose and an acrylic resin which is a polymerizate of acrylic and methacrylic ester, having a molecular weight of at least 100,000 and comprising units of formula: ##STR1## wherein: R.sub.1 is hydrogen or methyl,R.sub.2 is methyl or ethyl,R.sub.3 is methyl; andR.sub.4 is --CH.sub.2 --CH.sub.2 N(CH.sub.3).sub.3 Clthe resin containing 5% of trimethylammonium methacrylate chloride units by weight.
    Type: Grant
    Filed: July 26, 1990
    Date of Patent: May 12, 1992
    Assignee: Synthelabo
    Inventors: Howard Stevens, Maryvonne Chariot, Francoise Arnold, Gareth Lewis